Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Taste receptor type 2 member 18 pseudogene (TAS2R18P) is one of the human type 2 taste receptor (TAS2R) family pseudogenes that has lost its ability to code for a functional protein, either through the accumulation of disabling mutations or through evolutionary processes[1][3]. TAS2R18P is related by sequence to the family of G protein-coupled receptors (specifically bitter taste receptors) but contains frameshift insertions and a species-specific stop codon that disrupt its reading frame, making the gene non-functional in modern humans, Neanderthals, and Denisovans[1]. While TAS2R18P itself is non-functional in living humans, its evolutionary history suggests it may once have encoded a specialized bitter taste receptor shortly after the human–chimpanzee divergence. It became a pseudogene before the divergence of modern and archaic human lineages. TAS2R18P is not associated with any known biomarkers, drug interactions, or therapeutic applications; it has importance primarily in the study of evolution and human population genetics[1][3].
Not applicable; no functional receptor is produced.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taste receptor type 2 member 18 pseudogene (TAS2R18P).